translocation to the nucleus, to regulate genes important in endothelial survival and growth. 6, 7 Human PAECs deficient in βC failed to form functional vessels in a murine model of angiogenesis. 6 Based on our findings, we reasoned that constitutive activation of βC in a patient with dysfunctional BMPR2 signaling could protect the pulmonary endothelium against injury by promoting PAEC survival and might induce regeneration of lost vessels by stimulating PAEC growth.
To test this hypothesis, we used the adenomatous polyposis coli (Apc Min/+ ) mouse in which constitutive elevation of βC in all tissues results from truncation and functional loss of an APC allele. Mice develop colonic polyps in a manner similar to that seen in patients that suffer from familial adenomatous poliposis (FAP), an autosomal-dominant disease also associated with loss of function mutations in APC. 8 We exposed Apc Min/+ mice to chronic hypoxia, a stimulus that is known to produce pulmonary hypertension (PH) and loss of small distal PAs. 9 In this study we show that, contrary to our expectations, Apc Min/+ mice developed worse PH and demonstrated greater distal PA loss compared with control C57Bl6J (C57) littermates. In cell culture studies, we show that microvascular (mv) PAECs from Apc Min/+ compared with control (C57) littermate mice demonstrate reduced survival and tube formation associated with decreased adhesion to extracellular matrix proteins, in particular to laminin (LN). We identify a novel interaction between APC and a cytoplasmic domain in the α3 integrin, and show that this interaction is required for activation of integrin-linked kinase (ILK)-1, formation of focal adhesions, and induction of phospho Akt (pAkt). Furthermore, mvPAECs isolated from IPAH patients express less APC, and transfection of APC reverses impaired tube formation of these cells. Taken together, our findings reveal a novel role for APC in mediating PAEC adhesion and survival, suggesting that reduced expression or activity of APC could increase the risk of developing PH in individuals that may be susceptible because of the specific environmental exposures and abnormalities in other genes, such as BMPR2.
Methods
An expanded Methods section is available in the Online Data Supplement.
Hemodynamic and Morphometric Studies in Mice
The Animal Care Committee at Stanford University approved all the experimental protocols used in this study. Animals used in the experiments were obtained by crossing a male C57 Apc Min/+ with a female C57 mouse. For hypoxia studies, mice were placed in a hypoxia chamber where they were exposed to 10% inspired O 2 with access to food and water ad libitum for 3 weeks. Echocardiographic measurements of cardiac function and right ventricular systolic pressure (RVSP), left ventricular end diastolic pressure, and heart rate were measured under isoflurane anesthesia (1.5%-2.5% in 2 L O 2 / min) in unventilated mice using a closed-chest technique as previously described. 10 
Cell Culture
Primary human mvPAECs and EC growth medium were obtained from Sciencell (Sciencell, Carlsbad, CA). Cells were grown in EC growth medium and used between passages 4-8. Cells were starved in EC starvation medium (0.2% fetal bovine serum and gentamycin/amphotericin) for 24 hours before the experiment. For hypoxia studies, cells were placed in a hypoxia chamber (Biospherix, New York, NY) that provided 1% O 2 concentration for 24 hours.
Mouse mvPAEC were isolated from lung tissue as previously described. 7 To ensure the purity of the culture, we repurified these cultures with CD31 antibody-coated beads after the first passage.
Adhesion Assay
A 96-well plate coated with either fibronectin (FN), collagen IV (CIV), or LN was seeded with human mvPAECs (20 000 cells/well) and incubated at 37°C for 30 minutes. The average number of adherent cells was calculated by counting the total number of cells in 6 random fields per well (magnification ×200).
Integrin Blockade Assay
Cells were incubated with integrin blocking antibodies (α1, α2, α3, α4, α5, αV, α6, β1, and β4, Millipore, Billerica, MA) for 1 hour at 4 o C and then seeded in FN, CIV. or LN-coated 96-well plates. The average number of adherent cells was calculated as described above.
Plasmids and Transfection Methods
A pCMV-Neo-Bam plasmid containing the Homo sapiens wild-type APC sequence was a kind gift from Dr Bert Vogelstein (Johns Hopkins University). Plasmids containing inserts with the integrin α3 and α4 sequences in a pBluescript II KS (Sac to Kpn polylinker orientation) phagemid were obtained from American Type Culture Collection. The short interfering RNA (siRNA) duplexes (Dharmacon, Lafayette, CO) specific for βC (Dharmacon on-target plus; accession number NM_001012329, NM_020248), and APC (Ambion-validated siRNA, Ambion, Grand Island, NY), were transfected into human mvPAECs using a Nucleofector II (Program T-032) using the basic endothelial Nucleofection Kit (Lonza, Basel, Switzerland).
Generation of the ΔITGA3 and Integrin Chimeric Mutants
For generation of the integrin chimeras, the cytoplasmic tail of α3 (3039G-3136A) or α4 (3129C-3225C) was excised from their native sequence and swapped followed by subcloning into a pcDNA 3.1 vector. For the generation of the integrin alpha (ITGA)3 mutant (Δα3), we substituted the serines found in the QPSXXE motif with alanines as illustrated below:
AGCCCAGCCGTCAGAGACAGA (native sequence) AGaCCAGCCGgCAGAGACcGA (mutant sequence) Site-directed mutagenesis and Chimera generation were performed at Mutagenex Labs (Mutagenex, Somerset, NJ). 
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Statistical Analysis
The number of samples or animals studied per experiment is indicated in the figure legends. Values from multiple experiments are expressed as mean±SEM. Statistical significance was determined using unpaired t test or 1-way ANOVA followed by Dunnett or Bonferroni multiple comparison tests unless stated otherwise. A value of P<0.05 was considered significant.
Results
Apc Min/+ Mice Demonstrate Greater RVSP, Right Ventricular Hypertrophy, and Reduction in Small Distal PAs After Chronic Hypoxia and Recovery in Room Air
To determine whether increased levels of total βC in the pulmonary circulation protect against small distal PA loss and development of PH, we placed 15-week-old male and female Apc Min/+ and C57 wild-type littermate control mice in a hypoxia chamber (fractional inspired oxygen: 10%) for 3 weeks, and compared their structural and functional response immediately after exposure, and after 3 weeks of recovery in room air, as in our previous studies. 10 Compared with C57, the Apc Min/+ mice of both genders developed more severe PH as judged by significantly higher RVSP after 3 weeks of hypoxia not attributable to a change in left ventricular end diastolic pressure. Moreover, the elevation in RVSP persisted after 3 weeks of recovery in room air ( Figure 1A ). Consistent with these findings, Apc Min/+ mice, when compared with C57, had greater right ventricular hypertrophy as judged by Fulton index (the ratio of the right ventricle to left ventricle and septum), both after chronic hypoxia and after the room airrecovery period ( Figure 1B ). Of note, differences in Fulton index were solely because of the increase in right ventricle mass as no significant differences in left ventricle + septum mass were seen between C57 and Apc Min/+ mice in any of the experimental conditions. Similar values for RVSP and right ventricular hypertrophy were observed in C57 and Apc Min/+ mice maintained over the same period of time exclusively in room air ( Figure 1A-B ). Chronic hypoxia-induced PH is associated with muscularization of normally nonmuscular small distal alveolar duct and wall arteries, and Apc Min/+ and C57 mice demonstrated a similar increase in the muscularization of these vessels after chronic hypoxia and recovery ( Figure 1C ). However, we observed a significant reduction in the number of these distal vessels in the Apc Min/+ versus C57 mice in chronic hypoxia that, in contrast to the control group, failed to normalize at the end of the recovery period ( Figure 1D ).
Echocardiographic analyses in the C57 and Apc Min/+ mice after chronic hypoxia and recovery in room air revealed similar values for left ventricular function as judged by fractional shortening, cardiac output, ejection fraction, and heart rate (Online Figure IA-D). Systemic blood pressure (Online Figure IE) , left ventricular end diastolic pressure (Online Figure IF) , and pulmonary artery acceleration times (Online Figure IG) were also similar in both genotypes under all conditions of study. Similar values for left ventricular end diastolic pressure and cardiac output suggested that the elevated RVSP could represent an increase in pulmonary vascular resistance. However, the hematocrit levels were lower in the Apc Min/+ versus C57 mice in room air (30%±5% versus 40%±10%) and hypoxia (54±10 versus 65±8%). We then set out to investigate how, despite the heightened βC expression in Apc Min/+ mice, there could be increased hypoxia-mediated loss of small distal PAs and impaired recovery in room air.
Apc Min/+ mvPAECs Demonstrate Reduced Survival After Serum Withdrawal but a Preserved Proliferative Response Under Normoxia and Hypoxia
We harvested mvPAECs using CD31 antibody-coated beads (see Methods) to determine whether the impaired survival of these cells when exposed to hypoxia could be a cause of loss of vessels in the Apc Min/+ mice. Compared with C57, Apc Min/+ mvPAECs demonstrated a >50% reduction in APC protein, accompanied by an increase in total βC (Figure 2A ). Apc Min/+ and C57 cells were then either incubated in room air (fractional inspired oxygen, 21%) or in a hypoxia chamber (fractional inspired oxygen, 1%) for 24 hours, as described in the Methods section, and both genotypes were exposed to decreasing serum concentrations ranging from 10% (full growth medium) to 0% (serum free). Impaired cell survival or apoptosis, judged by active caspase 3/7, was significantly greater in Apc Min/+ versus C57 mvPAECs and correlated with decreasing serum supplementation in normoxia ( Figure 2B , left) that was further aggravated by hypoxia ( Figure 2B , right).
Next, we compared the proliferative response of the Apc Min/+ versus C57 mvPAEC in response to an angiogenic stimulus. We counted the cells 24 hours after stimulation with vascular endothelial growth factor at concentrations ranging from 0 to 50 ng/mL. 11 We observed a lower initial number of adherent Apc Min/+ versus control mvPAECs cells, but the rate of proliferation of the Apc Min/+ cells that did adhere was comparable to that of C57 mvPAECs in both normoxia ( Figure 2C , left) and hypoxia ( Figure 2C , right).
Although most studies show that elevated βC is a survival factor in mammalian cells, there are reports that excessive βC can also be linked to apoptosis. 12 We, therefore, investigated whether the impaired survival of the Apc Min/+ mvPAEC could be linked to elevated βC levels. Apc Min/+ cells were transfected with either scrambled or βC-specific siRNA, with the goal of reducing endogenous βC levels to those seen in C57 cells (see Figure 2A ). After confirming that βC levels were reduced to the target range (Online Figure IIA) , we starved the cells and measured active caspase 3/7 as an indication of apoptosis (see Methods). We found no difference in apoptosis in Apc Min/+ mvPAEC treated with βC siRNA versus scrambled siRNA after 24 hours (Online Figure IIB ), suggesting that elevated βC levels are not responsible for the reduced survival of Apc Min/+ mvPAEC.
APC Deficiency Is Associated With Reduced Tube Formation in Matrigel
To further understand the consequences of reduced APC on angiogenesis, we seeded Apc Min/+ and C57 mvPAECs in wells coated with matrigel, a biological matrix similar in composition to the endothelial basement membrane. 13 We found that, after 30 minutes, significantly fewer Apc Min/+ versus C57 cells attached to matrigel ( Figure 3A) , and Apc Min/+ December 7, 2012 mvPAECs formed less complex tube networks when assessed 6 hours after seeding ( Figure 3B ). In association with reduced adhesion of Apc Min/+ mvPAECs to matrigel, we observed impaired formation of focal adhesions in these cells, as assessed by vinculin and actin staining ( Figure 3F −H versus 3C−E), as well as reduced clustering of microtubules at the cell periphery (Online Figure III ).
Adhesion Defect of APC-Deficient mvPAECs Is Prominent on LN
It has been proposed that APC is required for cell adhesion to the extracellular matrix by promoting the activation of integrin complexes and their association with the underlying actin cytoskeleton. 14, 15 To determine whether the adhesion defect of Apc Min/+ mvPAECs is selective to a specific component of the extracellular matrix, we used human mvPAECs transfected with either scrambled or APC-targeting siRNA and measured APC expression using an antibody in which the specificity for APC was validated using mass spectrometry (see Methods). A >50% reduction in APC protein was documented 48 hours after transfection, associated with a greater than 2-fold increase in βC ( Figure 4A ). Similar to Apc Min/+ mvPAECs, APC siRNA-treated mvPAECs demonstrated a preserved growth response to vascular endothelial growth factor in reduced serum conditions (Online Figure IVA) but reduced survival when incubated in hypoxia (Online Figure IVB) . Reduced expression of APC by siRNA resulted in a mild (10%-20%) decrease in adhesion to FN ( Figure 4B ) and a somewhat more impaired adhesion (30%-40%) to CIV ( Figure 4C ) at all tested concentrations of substrate. Adhesion of human APC siRNA-transfected mvPAECs to LN was, however, severely reduced (>80%) relative to adhesion to an uncoated substrate and failed to improve despite an increase in the amount of LN coating ( Figure 4D ). The reduced adhesion to all 3 substrates was unrelated to elevated levels of βC, as shown in experiments using βC-targeting siRNA to reduce βC levels in Apc Min/+ mvPAECs ( Figure 4E ).
LN Interaction With α3β1 Integrin Triggers an Interaction With Cytoplasmic APC in mvPAECs
To determine which integrin receptor complex 16 regulates adhesion of human mvPAECs to LN, we incubated cells with blocking antibodies against specific α and β integrins before seeding (see Methods). Although adhesion to LN was reduced with high concentrations of α1, α4, α5, and αV blocking antibodies, and with lower concentrations of α6 and β4 blocking antibodies, the most profound effect was noted with the blockade of α3 and β1 integrins (Online Figure VA) . Binding to extracellular matrix proteins can result in conformational changes that facilitate the formation of active signaling complexes on αand β-integrin cytoplasmic tails 17 that can impact cell adhesion and survival. To establish whether LN promotes recruitment of APC to the cytoplasmic tail of the β3 integrin to enable signaling, we first immunoprecipitated human mvPAEC lysates after 1 hour of exposure to LN using antibodies specific to this integrin, followed by western immunoblot for APC. We also assessed APC interaction with the α1 -integrin in cells adherent to CIV, or with α5 integrin in cells plated on FN. We found that although APC can associate with all of these α-integrins, there was a striking increase in Camptothecin was used as a positive control. C, Proliferation was assesed by cell count assays in C57 and Apc Min/+ mvPAECs exposed to a range of vascular endothelial growth factor (VEGF) concentrations (0−50 ng/mL) under either normoxia (left) or hypoxia (right). Cell numbers were measured 72 hours after the addition of VEGF as described in the Methods section. Bars represent mean±SEM from N=3 experiments. *P<0.01, **P<0.001, ***P<0.0001 vs C57 at 10% fetal bovine serum (FBS; apoptosis assay) or baseline (VEGF proliferation assay); #P<0.01, ##P<0.001, ###P<0.0001 vs C57, 1-way ANOVA with Bonferroni posttest. FiO 2 indicates fractional inspired oxygen. Figure VB) . Taken together, our studies suggest that binding to LN induces recruitment of APC to the α3-(likely β1) integrin complex. We next sought to examine the nature of this interaction and why recruitment of APC to the α3 integrin is required for adhesion to LN.
LN-Dependent APC Binding to α 3 Integrin Facilitates Focal Adhesion Complex Formation by Selectively Activating ILK-1
Binding of the integrin receptor complex to the extracellular matrix triggers a sequence of intracellular events that not only stabilizes cell-matrix interactions but also controls cell survival. Central to these biological events is the recruitment of ILK-1, a 52-kDa protein composed of 3 structurally distinct domains: 3 ankyrin repeats near the N terminus, a short linker sequence, and a kinase domain at the C terminus. 18, 19 Activation of cytoplasmic adaptor proteins, such as paxillin and vinculin, via direct or indirect binding to ILK-1 is necessary for the formation of mature integrin-actin focal adhesion complexes. Thus, a reduction in ILK-1 expression or activity can change cell shape and decrease the strength and number of focal adhesions. 19 Indeed both proteins colocalize at the cell periphery at the site of focal adhesions 18, 19 (Online Figure  VI ), suggesting that they may cooperatively interact in the mechanism responsible for cell adhesion to the extracellular environment.
To determine whether APC is required for the recruitment of ILK-1 to integrin receptors on binding to extracellular substrates, we performed coimmunoprecipitation studies. Using α-integrin antibodies, we precipitated protein complexes in cell lysates from human mvPAECs treated with either scrambled or APC siRNA after binding to CIV, FN, and LN, and then carried out Western immunoblotting for ILK-1. We found that the amount of ILK-1 precipitated using the α3 integrin antibody was independent of the extracellular matrix substrate (LN, CIV, or FN) to which the cells adhered ( Figure 5A ) and was preserved despite reducing levels of APC ( Figure 5A ). Thus, recruitment of ILK-1 by the α3 integrin is independent of its interaction with APC, even on LN. We next determined whether APC deficiency could influence ILK-1 activation. We incubated ILK-1 precipitated from lysates of human mvPAEC seeded on FN, CIV, and LN with GSK3β, a known substrate of ILK-1 (see Methods). We found that GSK3β phosphorylation by ILK-1 was higher in cells cultured on LN compared with CIV and FN. Moreover, ILK-1 activity was reduced in cells treated with APC-targeting siR-NA when cultured on LN, but not in cells cultured on FN or CIV ( Figure 5B) . Thus, the increase in APC associated with the α3 integrin in mvPAECs seeded on LN is a requirement for the activation of ILK-1.
ILK-1 activation also increases cell survival via the protein kinase B/Akt signaling pathway. 20 Given the poor survival response seen in APC-deficient mvPAECs (see Figure 2 ), we investigated whether loss of APC by APC-targeting siRNA reduced activation of protein kinase B/Akt in mvPAECs cultured on LN versus cells cultured on CIV or FN. Although there was considerable variability in the levels of pAkt (ie, protein kinase B active) in mvPAECs on the different substrates, reducing APC decreased pAkt only in LN-bound cells ( Figure 5C ).
Taken together, these studies in human mvPAECs cultured on LN show that the interaction between APC and the α3 integrin is required for the activation of ILK-1 and that ILK-1 activity promotes both adhesion of mvPAEC on LN and survival via protein kinase B/Akt (Figure 8 ).
Adhesion to LN Is Dependent on the QPSXXE Motif of α3 Integrin
The next series of experiments was carried out to determine whether the specific interaction of APC with the α3 integrin that is required for ILK-1 activity is also required for cell adhesion to LN. The cytoplasmic portion of the α3 integrin is composed of 52 amino acids and can undergo a series of posttranslational modifications. One such modification is the phosphorylation of serine 1042 within the QPSXXE motif that strengthens adhesion to LN via paxillin and focal adhesion kinase activity. 21 Given the specificity of our findings, we hypothesized that the association of APC with the α3 cytoplasmic tail would promote cell adhesion independent of the extracellular substrate. To this end, we engineered an integrin chimera in which the cytoplasmic tail of the α3 integrin was switched with that of the FN-specific integrin, α4 (α3Δ4) [22] [23] [24] and another in which the α4 cytoplasmic tail was switched with that of the α3 integrin (α4Δ3) (schema in Figure 6A ). We transfected these constructs individually into mvPAECs cotransfected with either scrambled or APC siRNA. We found that cells transfected with the α4 chimera (α4Δ3) demonstrated loss of adhesion to FN after treatment with APC siRNA ( Figure 6B ) whereas the α3 chimera (α3Δ4) demonstrated preserved LN adhesion despite transfection with APC siRNA ( Figure 6C ). As expected, under conditions of reduced APC, we also observed reduced LN binding in both vector and α4Δ3-transfected human mv-PAECs ( Figure 6B ).
We also investigated whether disruption of the QPSXXE sequence in the α3 integrin cytoplasmic tail, which contains the serine residue critical to LN binding (S1042), could reproduce the adhesion defect seen with APC deficiency. To this end, we mutated the QPSXXE motif in the α3 integrin cDNA sequence by substituting alanines for serines within the motif ( Figure 6A ). Consistent with our expectation, we found that cells transfected with the mutant α3 integrin construct (Δα3) demonstrated reduced adhesion to LN, compared with cells transfected with an empty vector ( Figure 6D ).
Taken together, our results demonstrate that when human mvPAECs bind LN, a functional QPSXXE motif in the cytoplasmic tail of the α3 integrin recruits APC to activate ILK-1, stabilize focal adhesions, and activate pAkt ( Figure  8 ). This property is not unique to mvPAECs, as we also documented reduced adhesion to LN compared with FN and CIV in the SW480 colon cancer cell line that expresses a truncated version of APC missing the cytoplasmic tail (Online Figure VII ).
Reduced APC Expression in mvPAECs From IPAH Patients Is Related to Decreased Adhesion and Tube Formation
Previous studies showed that PAECs isolated from IPAH patients demonstrate reduced survival and form smaller vascular tube networks compared with those of healthy donors, 25 but the mechanism involved was poorly understood. To determine whether the reduced angiogenic potential of IPAH mvPAECs could be related to decreased expression of APC, we isolated cells from the lungs of 5 healthy subjects (unused donor lungs) and lungs explanted from 5 IPAH patients undergoing lung transplant (see Online Table I for patient characteristics). These cells were obtained from tissues procured through the Pulmonary Hypertension Breakthrough Initiative (see Methods). We confirmed reduced tube formation in matrigel in mvPAECs from IPAH patients compared with those from healthy donors ( Figure 7A ). IPAH mvPAECs exhibited decreased adhesion to LN-coated surfaces ( Figure 7B ) compared with healthy donor mvPAECs, associated with lower levels of APC as demonstrated by Western immunoblot ( Figure  7C ) and immunohistochemistry ( Figure 7B ). As with APC siRNA-treated mvPAECs ( Figure 7B ), we found evidence of reduced ILK-1 activation in IPAH mvPAECs incubated with LN ( Figure 7D ). To determine whether the APC deficiency is directly responsible for the adhesion defect seen in IPAH mvPAECs, we transfected these cells with an APC expression construct. When transfected in healthy donor cells, wild-type APC protects against apoptosis secondary to hypoxia supporting its role as a prosurvival factor (Online Figure VIII) . APCtransfected IPAH mvPAECs recovered the ability to adhere to LN (Online Figure IX) and, when seeded in matrigel, were able to form vascular networks of similar size and density as those produced by healthy donor mvPAECs ( Figure 7D ).
Discussion
Based on our findings, we propose that in mvPAECs, APC promotes cell survival in response to formation of α3 integrin-rich focal adhesions on binding to LN (Figure 8 ). Interaction of QPSXXE motif of the α3 integrin cytoplasmic tail with APC is a prerequisite for the activation of ILK-1, formation of focal adhesions, and phosphorylation of pAkt to mediate cell survival. To the best of our knowledge, this is the first demonstration that APC can promote mvPAEC survival independent of its role in regulating Wnt signaling. Moreover, a reduction in APC appears to contribute to the decreased angiogenic potential of mvPAECs in IPAH patients. 25 Although the current findings appear to contradict our previous work on the proangiogenic effects of βC in BMP-stimulated PAECs, 6 we have discovered a novel function of APC that also promotes cell survival.
Since its original characterization, studies of the Apc Min/+ mouse established a firm link between increased Wnt/βC activation and development of colonic polyps. However, few studies have investigated whether there is a vascular phenotype in these animals, or whether APC might play a role in tumor pathogenesis independent of Wnt signaling. A study by Bhandaru et al 26 demonstrated that, compared with C57 controls, Apc Min/+ mice have higher than normal blood pressure and blood volume as a consequence of increased aldosterone levels and reduced glomerular filtration. In our study, we found only a trend toward higher systemic blood pressures in Apc Min/+ mice using tail-cuff measurements. Our results may be related to lower salt content in the diet, the timing of the blood pressure measurements (early morning versus afternoon), and a smaller sample size. Furthermore, hypoxia is known to trigger systemic vasodilatation and to inhibit the release of aldosterone from the adrenal glands, thus, promoting a reduction in systemic pressure. 27 We show that Apc Min/+ mice exposed to chronic hypoxia develop more severe PH in association with greater loss of peripheral PAs and impaired ability to regenerate these vessels during the recovery period. A recent study in mammalian cells revealed that APC mRNA and protein levels fall in response to hypoxia as a result of repression of the APC promoter by hypoxia inducible factor-1α, 28 a phenomenon that we were able to reproduce in human mvPAECs incubated in hypoxia (fractional inspired oxygen: 1%) for 24 hours (Online Figure X) . It is surprising that the hypoxia-mediated endothelial apoptosis and loss of vessels and the exaggerated PH in the Apc Min/+ versus C57 mice were not accompanied by greater muscularization of peripheral arteries as is seen in other murine models of PH. This may, however, be related to a confounding effect of loss of APC in PA smooth muscle cells. Future studies creating a transgenic mouse with EC-or smooth muscle cell-specific deletion of APC would allow us to better understand the nature of the smooth muscle cell response to APC deletion. Finally, it is also intriguing that mice develop PH only when exposed to hypoxia even though they can develop malignant tumors at baseline.
A prominent finding in our studies in APC-deficient mvPAECs was the relative specificity of the adhesion defect to LN and LN-enriched substrates, such as matrigel. Because the basement membrane of blood vessels is rich in LN, inability to properly attach to this substrate would substantially impair the physiological angiogenic response to a vascular injury. 29, 30 In HeLAS3 cells, microtubule-associated APC is recruited to focal adhesions by disheveled after the binding of Wnt5a to the Wnt receptor frizzled 2. 15, 31 In this setting, it was thought that APC is brought in close proximity to the integrin receptors by its association with disheveled and frizzled 2 and that this fosters cytoskeletal changes that influence cell adhesion, polarity, and directed migration. Our studies demonstrate not only that there is a physical interaction between APC and the α3 integrin but that this interaction is required for ILK-1 activity and stabilization of focal adhesions. Moreover, this interaction can only occur if the QPSXXE motif in the α3 cytoplasmic tail is preserved. 21 At the center of the interaction between LN, α3 integrin and APC is the activation of ILK-1, a protein that facilitates integrin-actin interactions and activates numerous signaling pathways in response to integrin binding to the extracellular matrix. 32, 33 Our studies show that the α3 integrin can recruit ILK-1 independent of APC but that the APC interaction with α3 integrins clustering on LN is required to activate ILK-1. Other intermediary proteins like APC can promote a functional interaction between integrin receptors and ILK-1 and are likely associated with mvPAEC binding to other substrates. An example is the calponin homology ILK-binding protein (or α-parvin/actopaxin), an integrin adaptor protein that binds β1 integrin and recruits ILK-1 by interacting with its C terminal. 34, 35 This event also ensures the activation of ILK-1 and consequent or concomitant downstream signaling via protein kinase B (pAkt).
In contrast to the strong APC-dependent activation of ILK-1 seen in LN-bound mvPAECs, the extent of ILK-1 activation seen in cells cultured on FN or CIV was minimal and did not correlate with pAkt activation. One possible explanation for this observation is that FN and CIV-specific integrin receptors preferentially used focal adhesion kinase, to ensure maturation of focal adhesion complexes and to trigger activation of pAkt. Indeed, studies performed in mesenchymal stem cells, intestinal epithelial cells, and human umbilical vein ECs 36, 37 have demonstrated that both CIV and FN promote focal adhesion formation and pAkt through activation of focal adhesion kinase. 38, 39 It was interesting that transfection of a constitutively active Akt expression construct failed to reverse or improve survival of APC-deficient cells (Online Figure XI) . Based upon previous studies, it is probable that recruitment of APC to the LN-bound α3β1 integrin complex initiates a signaling cascade involving additional survival pathways responsible for protecting mvPAECs during stress and injury. Alternatively, recruitment of constitutively active Akt to the integrin cytoplasmic scaffold is necessary to properly target signaling to downstream effectors of survival. 40 Reduced APC levels in SW480 colon cancer cells 41 could contribute to heightened metastatic behavior by allowing the cells to detach from the LN-based extracellular matrix and assume an invasive phenotype. In a study investigating 22 colorectal cancer cell lines with different levels of APC expression, a strong correlation was found between CpG methylation in 2 regions of the APC promoter and the degree of reduced APC expression. 42 Moreover, treatment of colon cancer cells with 5-aza-2′-deoxycytidine, a known DNA methyltransferase inhibitor, reduced CpG methylation and concomitantly increased levels of APC. Other agents with demethylating properties, such as selenite, also increase levels of APC in prostate cancer cells and reduce tumor growth and metastasis. 43 It is possible that these strategies to increase APC could be used to reverse the angiogenic defect in IPAH mvPAECs, as we showed, by transfecting the cells with an APC construct.
Although the mechanism leading to a reduction in APC in IPAH mvPAECs is unknown, several possibilities could be explored. Using a microRNA (miR) microarray to analyze colorectal cancer cells exposed to the novel antineoplastic agent CM-1, Li et al discovered that CM-1−dependent suppression of miR-135a/b was associated with an increase in APC expression and anticancer activity. 44 Also, Nagel et al 45 found that untreated colorectal cancer cells exhibit higher level of miR-135a/b that was inversely related to APC expression. Other miRs, such as miR-27, suppress APC expression in osteoblasts and this regulates their differentiation. 46 Thus, it is possible that in IPAH cells there is an increase in miR-135a/b or in miR-27. Caruso et al 47 described a different miRNA expression profile in IPAH compared with control lungs but miR-135a/b and miR-27 were not mentioned in their study.
Given the potential clinical relevance of our findings, the fact that there is no reported link between FAP and PAH is surprising. Recent reports describe increased vascularity in the oral mucosa of patients with FAP, which contrasts with our findings in the lungs of Apc Min/+ mouse. 48 A possible explanation for this discrepancy may be related to an inherent difference in the subendothelial matrix of systemic versus pulmonary microvessels. Alternatively environmental hypoxia may also cause systemic microvessel dropout. That is, specific environmental and genetic modifiers may be necessary to unmask FAP or PAH. It is conceivable that patients who are carriers of the BMPR2 mutation may be at a higher risk of developing IPAH when they have loss of function of APC. It is also possible that some patients with FAP have mild or moderate PH, but their symptoms are masked by the underlying pathology of their colonic condition, or that some patients with BMPR2 mutations and PAH have mild colonic disease.
Given the rarity of both conditions (ie, the lack of penetrance of the APC mutation in causing colonic disease 49, 50 and the BMPR2 mutation in causing PAH), it is likely that screening FAP patients with APC mutations for PAH may be necessary to further characterize the presence of PAH in FAP, as well as the contribution of reduced APC to IPAH, particularly in patients with BMPR2 dysfunction.
